Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres








Gamme d'année
1.
Acta Pharmaceutica Sinica ; (12): 108-112, 2002.
Article de Anglais | WPRIM | ID: wpr-343390

RÉSUMÉ

<p><b>AIM</b>To assess the effects of the alpha-glucosidase inhibitor Sangzhi (Ramulus mori, SZ) on the relief of diabetic symptoms of hyperglycemia and the prevention of its late complications in alloxan diabetic rats with high-calorie chow.</p><p><b>METHODS</b>The aqueous extract of Sangzhi was given orally to alloxan diabetic rats for 15 days. The hyperglycemic symptoms were observed. The blood glucose, lipid levels and the nephrotic representations were measured.</p><p><b>RESULTS</b>When alloxan diabetic rats on high-calorie chow were treated with SZ, the hyperglycemic symptoms were improved, the blood lipid levels were improved, the ratio of kidney over body weight and the blood N-acetyl-beta-D-glucosaminidase (NAG) activity were lowered. The degree of renal pathological changes was significantly reduced.</p><p><b>CONCLUSION</b>SZ may be useful for treating diabetes and its complications.</p>


Sujet(s)
Animaux , Mâle , Rats , Acetylglucosaminidase , Sang , Glycémie , Métabolisme , Diabète expérimental , Traitement médicamenteux , Métabolisme , Néphropathies diabétiques , Métabolisme , Modèles animaux de maladie humaine , Antienzymes , Utilisations thérapeutiques , Inhibiteurs des glycoside hydrolases , Hypoglycémiants , Pharmacologie , Utilisations thérapeutiques , Rein , Anatomopathologie , Morus , Chimie , Plantes médicinales , Chimie , Rat Wistar , Triglycéride , Sang , alpha-Glucosidase
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE